The Gastrointestinal Endoscopic Devices Market Size was USD 10.78 Billion in 2023, projected to reach USD 16.84 Billion by 2032 and grow at a CAGR of 5.11% over the forecast period 2024-2032.
To Get more information on Gastrointestinal Endoscopic Devices Market - Request Free Sample Report
This report identifies the rising incidence and prevalence of gastrointestinal disease, creating demand for more sophisticated diagnostic and therapeutic interventions. The research looks at the volume of gastrointestinal endoscopic procedures, in addition to prescription and use patterns of endoscopic equipment in various regions, mirroring differences in adoption levels and technology innovation. It also evaluates healthcare expenditure on gastrointestinal endoscopy, including regional breakdown of investment patterns and market growth. The study also discusses pricing trends of gastrointestinal endoscopic equipment, driven by innovation, competition, and reimbursement policies, as well as how changing regulatory and compliance trends affect market accessibility and product approvals.
Drivers
The increasing prevalence of gastrointestinal diseases such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD)
Based on the World Cancer Research Fund, colorectal cancer is the third most prevalent cancer globally, with more than 1.9 million new cases in 2023. Increasing demand for minimally invasive treatments because of their reduced recovery time and shorter hospital stays has further boosted demand for sophisticated endoscopic technologies. Further, technical advancements, including AI-based endoscopy, robot-assisted endoscopic procedures, and disposable endoscopes, have improved diagnostic efficiency and procedural accuracy. Firms like Boston Scientific and Medtronic have launched AI-integrated endoscopic imaging solutions that provide real-time abnormality detection, increasing early diagnosis rates. Additionally, growing government funds and initiatives for gastrointestinal disorder screening and awareness programs are fueling market expansion. For instance, the U.S. Preventive Services Task Force (USPSTF) has broadened colorectal cancer screening guidelines to adults beginning at age 45, propelling increased endoscopy procedure volumes. The increasing use of capsule endoscopy and single-use endoscopes to minimize cross-contamination risks also adds to market growth. All these factors cumulatively reinforce the increasing demand for gastrointestinal endoscopic devices.
Restraints
The high costs associated with advanced endoscopic systems and limited reimbursement policies in several regions.
Advanced endoscopy technology, including AI-based platforms and robotic endoscopy, has prices ranging from USD 50,000 to USD 200,000, which exceeds the budget for most small health centers and developing countries. Moreover, an insufficient number of trained endoscopists is a major hindrance to market expansion. Shortages of trained professionals are common in most areas, especially in LMICs, making access to higher-end gastrointestinal diagnostic and therapeutic interventions rare. The World Gastroenterology Organisation reports a large shortage of trained gastroenterologists, particularly in Asia and Africa. Reimbursement issues further slowdown the growth of the market since insurance coverage for sophisticated procedures and disposable endoscopes in some nations is still restricted. Most of the time, the patient pays out-of-pocket, which deters them from undergoing elective endoscopic procedures. In addition, reprocessing and sterilization concerns for reusable endoscopes continue to affect adoption because improper cleaning protocols have caused infection outbreaks in healthcare institutions. These financial and operational constraints pose challenges to broad adoption, especially among next-generation technologies.
Opportunities
The gastrointestinal endoscopic devices market presents significant opportunities, especially with the increasing adoption of AI and robotic-assisted endoscopy.
The use of artificial intelligence (AI) in endoscopic imaging has enhanced real-time polyp detection and computer-aided lesion classification, minimizing diagnostic errors. AI-based endoscopy systems, including Medtronic's GI Genius, help doctors identify precancerous lesions with greater accuracy. Moreover, the increasing need for single-use and disposable endoscopes is generating profitable opportunities for manufacturers. The worldwide surge towards infection control has contributed to rising use of Ambu A/S's aScope Gastro, an endoscope with one-time use reducing the threat of cross-contamination. Rising healthcare infrastructure and medical tourism in the developing world are also promising avenues, with India, Thailand, and Brazil being the notable spenders on endoscopic diagnostic units. A potential opportunity is also coming from increased demand for capsule endoscopy, an investigative modality that is non-invasive with good patient compliance. Growing use of tele-endoscopy for distant diagnostics, especially in rural regions, also creates additional growth opportunities. In addition, regulatory sanctions and encouraging policies favorable to endoscopic device innovation develop a conducive landscape for firms to introduce next-generation products. As the need for early diagnosis and minimal procedures increases, manufacturers that develop AI-based, disposable, and robot endoscopy will ride the emerging trends.
Challenges
The gastrointestinal endoscopic devices market faces several challenges, including regulatory hurdles, device recalls, and supply chain disruptions.
Strict regulatory standards for new endoscopic technology approval tend to result in market entry delays. For example, the FDA 510(k) clearance process demands substantial clinical data, which raises product development time and expense. Moreover, device recalls for malfunction or safety issues cause delays for manufacturers. Olympus recalled its bronchoscopes in 2023 due to possible contamination risks, sparking concerns regarding endoscopic device safety and reprocessing protocols. Supply chain interruptions, especially following global crises such as the COVID-19 pandemic, have affected the supply of critical endoscopic parts. The lack of semiconductor chips, which are essential for high-resolution imaging devices, has slowed down the manufacturing and delivery of advanced endoscopy systems. Patient reluctance towards endoscopic procedures because of discomfort, anxiety, and fear of complications is another significant challenge. In addition, hospital budgets in public healthcare environments restrict the implementation of costly next-generation endoscopic technology. These challenges must be met through streamlined regulatory channels, increased supply chain resiliency, and improved patient education programs to achieve greater endoscopic procedure acceptance.
By Type
Flexible gastrointestinal endoscopes led the market share in 2023, contributing 49.2% of the overall share. Their high usage is attributed to their use for diagnosing and treating a wide variety of gastrointestinal diseases with minimal pain for patients. Their capability to traverse complicated anatomical structures, combined with technological improvements in high-definition images and artificial intelligence-driven diagnostics, has increased their popularity as the first choice among medical professionals.
Disposable gastrointestinal endoscopes are experiencing the highest growth in the market, driven by the mounting focus on infection control and hospital-acquired infection (HAI) prevention. Increased regulatory pressure towards single-use medical devices, coupled with fears of cross-contamination arising from reusable endoscopes, have accelerated adoption in the hospital and outpatient markets. Further, the declining cost of reprocessing and enhanced operational efficiency are the major drivers for their increasing demand.
By End Use
Outpatient facilities dominated the market in 2023 with a 51.6% share, fueled by the growing trend toward ambulatory care and same-day procedures. The popularity of outpatient endoscopic procedures is highly attributed to cost savings, reduced patient waits times, and greater accessibility. Further, advances in minimally invasive technology have allowed more advanced procedures to be carried out outside the confines of conventional hospital facilities, further increasing outpatient endoscopy volumes.
The hospital sector is also expected to witness the highest growth in the coming years owing to the increasing incidence of complicated gastrointestinal diseases with a need for sophisticated endoscopic treatment. The growing implementation of robot-assisted and AI-based endoscopy in hospitals and increased patient flow for serious cases are promoting demand. Additionally, government efforts towards improving healthcare infrastructure and reimbursement policies will drive hospital-endoscopic procedure growth.
North America was the leading market for gastrointestinal endoscopic devices worldwide in 2023, commanding 32.5% of overall revenue. The region leads due to high incidences of gastrointestinal diseases like colorectal cancer, inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD). The region has a highly developed healthcare system, high acceptance rates of innovative endoscopic devices, and strong reimbursement policies in place that ensure rising procedural volumes. Besides, the competitive presence of key market players like Olympus Corporation, Boston Scientific, and Medtronic has further boosted innovation and penetration into the market. The increasing adoption of AI in endoscopy, coupled with growing demand for minimally invasive interventions, has further boosted North America's dominance in the industry.
The Asia-Pacific region is the region with the highest growth, fueled by increased healthcare expenditures, enhanced medical infrastructure, and growing awareness for early detection of disease. These nations, including China, India, and Japan, are experiencing high growth rates because of the growing geriatric population, which is more prone to gastrointestinal diseases. The growing use of disposable endoscopes to reduce the risk of cross-contamination and increasing medical tourism in nations like India and Thailand is also driving the demand for endoscopic procedures. Furthermore, government programs focused on increasing access to healthcare and enhancing endoscopic training schemes have driven the high market growth. Consequently, the Asia-Pacific region will witness the highest growth in the adoption of gastrointestinal endoscopic devices during the forecast period.
Get Customized Report as per Your Business Requirement - Enquiry Now
Key Players and Their Gastrointestinal Endoscopic Devices
Olympus Corporation – EVIS X1 Endoscopy System, GIF-HQ190 Gastroscope, CF-HQ190L/I Colonoscope
Boston Scientific Corporation – SpyGlass DS Direct Visualization System, Resolution 360 Clip, Expect Slimline Needle
Medtronic – PillCam SB3 Capsule Endoscopy System, Barrx Radiofrequency Ablation System, Emprint Ablation System
Johnson & Johnson Services, Inc. (Ethicon Inc.) – ENSEAL X1 Large Jaw Tissue Sealer, STRATAFIX Knotless Tissue Control Devices
KARL STORZ SE & Co. KG – C-MAC Video Gastroscope, Telepack+ Endoscopic Imaging System
Fujifilm Holdings Corporation – ELUXEO Video Endoscopy System, EG-760Z Gastroscope, EC-760R Colonoscope
Stryker – 1688 AIM 4K Endoscopic Camera, SPY Portable Handheld Imaging System
HOYA Corporation (PENTAX Medical) – i10 Series Video Endoscopes, DEFINA Endoscopy System, MagniView Gastroscope
Smith+Nephew – Dyonics RF System (used in GI applications for hemostasis)
Cook Medical – Hemospray Endoscopic Hemostasis System, Evolution Stent System, Fusion OMNI ERCP Cannula
CONMED Corporation – Beamer Endoscopic Electrosurgical Unit, TruPass Biopsy Forceps
Ambu A/S – aScope Gastro Disposable Endoscope, aScope Colon Disposable Endoscope
Richard Wolf GmbH – ENDOCAM Logic 4K Endoscopy System, ERAGONmodular Laparoscopic Instruments
STERIS plc – Celerity Endoscope Processing System, VaproSure Sterilization System
Recent Developments
In April 2024, Fujifilm launched Tracmotion, its Red Dot award-winning Endoscopic Submucosal Dissection (ESD) device, at Endocon 2024 in Delhi. The event, a key platform for gastroenterology advancements, showcased Tracmotion alongside innovative procedures and discussions shaping the future of endoscopic medicine.
In Jan 2024, the FDA granted 510(k) clearance to EndoSound for its Vision System, an innovative add-on endoscopic ultrasound device designed to attach to upper gastrointestinal endoscopes, enhancing imaging capabilities.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 10.78 billion |
| Market Size by 2032 | USD 16.84 billion |
| CAGR | CAGR of 5.11% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type [Rigid Gastrointestinal Endoscopes (Gastroscope (Upper GI Endoscope), Enteroscope, Sigmoidoscope, Duodenoscope), Flexible Gastrointestinal Endoscopes (Gastroscope (Upper GI Endoscope), Enteroscope, Sigmoidoscope, Duodenoscope, Colonoscope), Disposable Gastrointestinal Endoscopes (Gastroscope (Upper GI Endoscope), Enteroscope, Sigmoidoscope, Duodenoscope, Colonoscope)] • By End Use [Hospitals, Outpatient Facilities] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Olympus Corporation, Boston Scientific Corporation, Medtronic, Johnson & Johnson Services, Inc. (Ethicon Inc.), KARL STORZ SE & Co. KG, Fujifilm Holdings Corporation, Stryker, HOYA Corporation (PENTAX Medical), Smith+Nephew, Cook Medical, CONMED Corporation, Ambu A/S, Richard Wolf GmbH, STERIS plc. |
Ans: The Gastrointestinal Endoscopic Devices market is anticipated to grow at a CAGR of 5.11% from 2024 to 2032.
Ans: The market is expected to reach USD 16.84 billion by 2032, increasing from USD 10.78 billion in 2023.
Ans: The increasing prevalence of gastrointestinal diseases such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD).
Ans: The high costs associated with advanced endoscopic systems and limited reimbursement policies in several regions.
Ans: North America dominated the Gastrointestinal Endoscopic Devices market.
Table of contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Gastrointestinal Disorders (2023)
5.2 Gastrointestinal Endoscopic Procedures Volume (2020-2032)
5.3 Prescription & Usage Trends of Endoscopic Devices (2023), by Region
5.4 Healthcare Spending on Gastrointestinal Endoscopy, by Region (2023)
5.5 Pricing Analysis of Gastrointestinal Endoscopic Devices (2023)
Regulatory & Compliance Trends Impacting the Market (2023-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Gastrointestinal Endoscopic Devices Market Segmentation, by Type
7.1 Chapter Overview
7.2 Rigid Gastrointestinal Endoscopes
7.2.1 Rigid Gastrointestinal Endoscopes Market Trends Analysis (2020-2032)
7.2.2 Rigid Gastrointestinal Endoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Gastroscope (Upper GI Endoscope)
7.2.3.1 Gastroscope (Upper GI Endoscope) Market Trends Analysis (2020-2032)
7.2.3.2 Gastroscope (Upper GI Endoscope) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Enteroscope
7.2.4.1 Enteroscope Market Trends Analysis (2020-2032)
7.2.4.2 Enteroscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Sigmoidoscope
7.2.5.1 Sigmoidoscope Market Trends Analysis (2020-2032)
7.2.5.2 Sigmoidoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Duodenoscope
7.2.6.1 Duodenoscope Market Trends Analysis (2020-2032)
7.2.6.2 Duodenoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Flexible Gastrointestinal Endoscopes
7.3.1 Flexible Gastrointestinal Endoscopes Market Trends Analysis (2020-2032)
7.3.2 Flexible Gastrointestinal Endoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Gastroscope (Upper GI Endoscope)
7.3.3.1 Gastroscope (Upper GI Endoscope) Market Trends Analysis (2020-2032)
7.3.3.2 Gastroscope (Upper GI Endoscope) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Enteroscope
7.3.4.1 Enteroscope Market Trends Analysis (2020-2032)
7.3.4.2 Enteroscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Sigmoidoscope
7.3.5.1 Sigmoidoscope Market Trends Analysis (2020-2032)
7.3.5.2 Sigmoidoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.6 Duodenoscope
7.3.6.1 Duodenoscope Market Trends Analysis (2020-2032)
7.3.6.2 Duodenoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.7 Colonoscope
7.3.7.1 Colonoscope Market Trends Analysis (2020-2032)
7.3.7.2 Colonoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Disposable Gastrointestinal Endoscopes
7.4.1 Disposable Gastrointestinal Endoscopes Market Trends Analysis (2020-2032)
7.4.2 Disposable Gastrointestinal Endoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.3 Gastroscope (Upper GI Endoscope)
7.4.3.1 Gastroscope (Upper GI Endoscope) Market Trends Analysis (2020-2032)
7.4.3.2 Gastroscope (Upper GI Endoscope) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.4 Enteroscope
7.4.4.1 Enteroscope Market Trends Analysis (2020-2032)
7.4.4.2 Enteroscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.5 Sigmoidoscope
7.4.5.1 Sigmoidoscope Market Trends Analysis (2020-2032)
7.4.5.2 Sigmoidoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.6 Duodenoscope
7.4.6.1 Duodenoscope Market Trends Analysis (2020-2032)
7.4.6.2 Duodenoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.7 Colonoscope
7.4.7.1 Colonoscope Market Trends Analysis (2020-2032)
7.4.7.2 Colonoscope Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Gastrointestinal Endoscopic Devices Market Segmentation, by End-use
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Outpatient Facilities
8.3.1 Outpatient Facilities Market Trends Analysis (2020-2032)
8.3.2 Outpatient Facilities Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.4 North America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.5.2 USA Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.6.2 Canada Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.6.2 France Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 China Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 India Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 Japan Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.9.2 Australia Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.4 Africa Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.4 Latin America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Gastrointestinal Endoscopic Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Olympus Corporation
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Boston Scientific Corporation
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Medtronic
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Johnson & Johnson Services, Inc. (Ethicon Inc.)
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 KARL STORZ SE & Co. KG
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Fujifilm Holdings Corporation
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Stryker
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 HOYA Corporation (PENTAX Medical)
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Smith+Nephew
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Cook Medical
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Rigid Gastrointestinal Endoscopes
Gastroscope (Upper GI Endoscope)
Enteroscope
Sigmoidoscope
Duodenoscope
Flexible Gastrointestinal Endoscopes
Gastroscope (Upper GI Endoscope)
Enteroscope
Sigmoidoscope
Duodenoscope
Colonoscope
Disposable Gastrointestinal Endoscopes
Gastroscope (Upper GI Endoscope)
Enteroscope
Sigmoidoscope
Duodenoscope
Colonoscope
By End Use
Hospitals
Outpatient Facilities
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The 7T Magnetic Resonance Imaging Systems Market size was valued at USD 2.01 billion in 2023, projected to grow to USD 3.78 billion by 2032 with a 7.26% CAGR.
Overactive Bladder Treatment Market was valued at USD 3.63 billion in 2023 and is expected to reach USD 5.45 billion by 2032, growing at a CAGR of 4.64% over the forecast period 2024-2032.
Airway Disease Treatment Market was valued at $ 2.23 billion in 2023 and is expected to reach $ 3.54 billion by 2032, growing at a CAGR of 5.29% from 2024-2032.
The Diet Pills Market size is expected to reach USD 3.77 Bn by 2032 and was valued at USD 1.61 Bn in 2023, the CAGR is expected to be 9.9% over the forecast period of 2024-2032.
Fill-Finish Manufacturing Market Size was valued at USD 15.4 Billion in 2023 and is expected to reach USD 33.5 Billion by 2032, growing at a CAGR of 9.1% over the forecast period 2024-2032.
The Arthroscopy Market Size was valued at USD 6.23 billion in 2023 and is expected to reach USD 8.66 billion by 2032 and grow at a CAGR of 3.76% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
